做科研型结核病医生实现全球结核病战略目标

• 主编寄语 • 下一篇

沙巍()

沙巍. 做科研型结核病医生实现全球结核病战略目标[J]. 中国防痨杂志, 2018, 40(8): 785-787. doi: 10.3969/j.issn.1000-6621.2018.08.001

[1]	World Health Organization . WHO End TB Strategy. Geneva: World Health Organization, 2015.
[2]	World Health Organization . Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
[3]	王辰 . 临床研究是医生的天职天命. 转化医学杂志, 2015,4(2):65-67.
[4]	Fox W, Mitchison DA . Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis, 1975,111(3):325-353.
[5]	Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet, 1975,1(7899):119-124.
[6]	Controlled clinical trial of four short-course ( 6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. ( 6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet, 1974,2(7889):1100-1106.
[7]	阚冠卿 . 结核病化学疗法方案. 中国防痨通讯, 1988,10(4):145-149.
[8]	王振义.王振义: 我的医学人生. 中国医院院长, 2011,( 3):112-114.
[9]	吴绍青, 崔祥瑸, 王士伸 . 异烟肼对于结核病临床试用之研究. 中华医学杂志, 1953,2(7):482-493.
[10]	吴绍青, 谷镜汧, 郑子颖 , 等. 结核菌对异烟肼的耐药性与致病力的关系. 中华结核病科杂志, 1957,5(2):82-90.

RichHTML